Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

A company with the name and ticker symbol of ISIS seems unfortunate. But biotech Isis Pharma is developing an ALS drug any may benefit from the ice bucket challenge that's a social media craze.

  • untitled
CNNMoney assistant managing editor Paul LaMonica highlights the latest news from Wall Street and what's moving the markets in his daily investing commentary.